Mehmet Erdem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mehmet Erdem has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ozan Aydemir
YÜZÜNCÜ YIL ÜNİVERSİTESİ, TIP FAKÜLTESİ
4 shared publications - Murat Alay
Van Yuzuncu Yil Universitesi
2 shared publications - Nur Düzen Oflas
Department of Internal Medicine, Faculty of Medicine, Van Yuzuncu Yil University, 54100 Van, Türkiye
2 shared publications - Senar Ebinç
Department of Medical Oncology, Van Yuzuncu Yil University Faculty of Medicine, Van 65100, Türkiye
2 shared publications - Ahmet Murt
Division of Nephrology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul 34098, Turkey
1 shared publication - Aydan Mutis Alan
Division of Nephrology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul 34098, Turkey
1 shared publication
Latest Publications
- Open Access
- 9 November 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1983789
Explainable machine learning for predicting kidney disease progression defined by changes in estimated glomerular filtration rate in type 2 diabetes: a single-centre retrospective study
Background and objectives: Routine clinical data may contain information on the future course of kidney disease in type 2 diabetes mellitus (T2DM). This study assessed the predictive performance and interpretability of seven machine learning (ML) algorithms applied to baseline measurements. Materials and methods: This single-centre retrospective study included 382 patients with T2DM evaluated between January 2024 and December 2025. Progression was ascertained at a fixed three-month reassessment and defined according to KDIGO criteria as a decline in estimated glomerular filtration rate (eGFR) category with a fall of at least 25% from baseline or an increase in albuminuria category. Least absolute shrinkage and selection operator (LASSO) regression selected 22 of 52 candidate predictors before repeated stratified five-fold cross-validation, and a sensitivity analysis repeated the selection within training folds. SHapley Additive exPlanations (SHAP) and Local Interpretable Model-agnostic Explanations (LIME) were used to interpret the models. Results: Progression occurred in 162 patients (42.4%). The area under the receiver operating characteristic curve (AUC) was 0.682 for the radial-basis support vector machine (SVM) and 0.671 for LASSO logistic regression; when feature selection was repeated within training folds, the AUCs were 0.603 and 0.640, respectively. LASSO logistic regression was retained for interpretation because its coefficients are transparent and its AUC did not differ significantly from that of SVM. At the Youden threshold, its sensitivity, specificity, positive predictive value and negative predictive value were 0.648, 0.650, 0.577 and 0.715. The best full model did not differ significantly from the best seven-variable model (ΔAUC 0.046; p = 0.052). After Platt scaling, the Brier score of the LASSO model was 0.225 and the calibration slope 1.39. Diabetes duration, total cholesterol and ferritin were associated with progression in an exploratory multivariable analysis. Conclusions: Routine baseline data provided modest discrimination, part of which reflected optimism from feature selection performed before cross-validation. The incremental clinical value of the model has not been established, and external, preferably prospective, validation is required before clinical use.
- 9 November 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1983789
Open AccessExplainable machine learning for predicting kidney disease progression defined by changes in estimated glomerular filtration rate in type 2 diabetes: a single-centre retrospective study
Background and objectives: Routine clinical data may contain information on the future course of kidney disease in type 2 diabetes mellitus (T2DM). This study assessed the predictive performance and interpretability of seven machine learning (ML) algorithms applied to baseline measurements. Materials and methods: This single-centre retrospective study included 382 patients with T2DM evaluated between January 2024 and December 2025. Progression was ascertained at a fixed three-month reassessment and defined according to KDIGO criteria as a decline in estimated glomerular filtration rate (eGFR) category with a fall of at least 25% from baseline or an increase in albuminuria category. Least absolute shrinkage and selection operator (LASSO) regression selected 22 of 52 candidate predictors before repeated stratified five-fold cross-validation, and a sensitivity analysis repeated the selection within training folds. SHapley Additive exPlanations (SHAP) and Local Interpretable Model-agnostic Explanations (LIME) were used to interpret the models. Results: Progression occurred in 162 patients (42.4%). The area under the receiver operating characteristic curve (AUC) was 0.682 for the radial-basis support vector machine (SVM) and 0.671 for LASSO logistic regression; when feature selection was repeated within training folds, the AUCs were 0.603 and 0.640, respectively. LASSO logistic regression was retained for interpretation because its coefficients are transparent and its AUC did not differ significantly from that of SVM. At the Youden threshold, its sensitivity, specificity, positive predictive value and negative predictive value were 0.648, 0.650, 0.577 and 0.715. The best full model did not differ significantly from the best seven-variable model (ΔAUC 0.046; p = 0.052). After Platt scaling, the Brier score of the LASSO model was 0.225 and the calibration slope 1.39. Diabetes duration, total cholesterol and ferritin were associated with progression in an exploratory multivariable analysis. Conclusions: Routine baseline data provided modest discrimination, part of which reflected optimism from feature selection performed before cross-validation. The incremental clinical value of the model has not been established, and external, preferably prospective, validation is required before clinical use.
- Open Access
- 30 August 2026
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 19 (2) , 68-75
The Relationship Between Carotid Artery Intima Media Thickness and Mean Platelet Volume In Hemodialysis Patients
Objective: Chronic kidney disease is closely associated with cardiovascular disease. The prevalence and mortality rates of cardiovascular disease in patients with chronic kidney disease are significantly higher compared to those in the general population. Atherosclerosis is known to be the primary underlying pathology of cardiovascular disease, and carotid artery intima-media thickness (CIMT) is considered the most reliable indicator indicator of atherosclerosis. This study aimed to examine the relationship between mean platelet volume (MPV) and CIMT in patients undergoing hemodialysis. Methods: Data from 50 patients undergoing hemodialysis were retrospectively analyzed. Demographic characteristics, vital signs, chronic diseases, and laboratory results of the patients were collected. Descriptive statistics were expressed as mean, standard deviation, frequency, and percentage. Statistical analyses were performed using SPSS software (IBM SPSS for Windows, version 26), and a significance level of p<0.05 was considered statistically significant. Results: Elevated CIMT was found in 24 of the 50 patients studied. Mean platelet volume was higher in patients with elevated CIMT (11.57 fl) compared to those with normal CIMT (10.88 fl), and the difference between the groups was statistically significant (t-test sd: 0.98, p<0.05). Correlation analysis revealed a statistically significant, positive correlation between CIMT and MPV (r: 0.158, p<0.001). Conclusion: Mean platelet volume was found to be elevated in patients with increased CIMT. MPV is associated with atherosclerosis and suggesting MPV as a potential marker for cardiovascular risk in hemodialysis patients.
- 30 August 2026
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 19 (2) , 68-75
Open AccessThe Relationship Between Carotid Artery Intima Media Thickness and Mean Platelet Volume In Hemodialysis Patients
Objective: Chronic kidney disease is closely associated with cardiovascular disease. The prevalence and mortality rates of cardiovascular disease in patients with chronic kidney disease are significantly higher compared to those in the general population. Atherosclerosis is known to be the primary underlying pathology of cardiovascular disease, and carotid artery intima-media thickness (CIMT) is considered the most reliable indicator indicator of atherosclerosis. This study aimed to examine the relationship between mean platelet volume (MPV) and CIMT in patients undergoing hemodialysis. Methods: Data from 50 patients undergoing hemodialysis were retrospectively analyzed. Demographic characteristics, vital signs, chronic diseases, and laboratory results of the patients were collected. Descriptive statistics were expressed as mean, standard deviation, frequency, and percentage. Statistical analyses were performed using SPSS software (IBM SPSS for Windows, version 26), and a significance level of p<0.05 was considered statistically significant. Results: Elevated CIMT was found in 24 of the 50 patients studied. Mean platelet volume was higher in patients with elevated CIMT (11.57 fl) compared to those with normal CIMT (10.88 fl), and the difference between the groups was statistically significant (t-test sd: 0.98, p<0.05). Correlation analysis revealed a statistically significant, positive correlation between CIMT and MPV (r: 0.158, p<0.001). Conclusion: Mean platelet volume was found to be elevated in patients with increased CIMT. MPV is associated with atherosclerosis and suggesting MPV as a potential marker for cardiovascular risk in hemodialysis patients.
- 25 February 2026
- Published by MediHealth Academy in Journal of Current Hematology & Oncology Research
- Vol. 4 (1) , 12-17
Evaluation of demographic and clinical data of patients diagnosed with lung cancer: a single-center experience
Aims: To retrospectively evaluate the demographic, epidemiological, and clinical characteristics of patients diagnosed with lung cancer. Methods: Patients diagnosed and treated for lung cancer in our medical oncology clinic were included in the study. Patient records were obtained retrospectively from the electronic databases of the hospital. Demographic and clinical characteristics were recorded for each patient. Results: A total of 313 patients diagnosed with lung cancer were included in the study. Mean age was 62.7 ± 10.3 years. Of the patients, 83.4% were male and 16.6% were female. Most common presenting complaints were dyspnea (40.9%) and chest pain (32.2%). Smoking history was present in 66.5% of patients, and 15.3% had a history of tandoori smoke exposure. Radiologically, the most frequent tumor localization was the right upper lobe (38%). Most common histopathological types were squamous cell carcinoma (39.3%), adenocarcinoma (27.2%), and small cell carcinoma (20.1%). Most common disease stage at the time of diagnosis was stage IV (48.9%), followed by stage III (39%), II (10.9%), and I (1.3%). Mean OS was 14 ± 1.4 (range, 11.2–16.8) months. Higher ECOG performance scores and advanced stage were associated with poorer survival. Mean OS was 31 months for females and 13 months for males. Conclusion: The findings obtained in our study were found to be consistent with those of previous research. In Turkey, the high prevalence of smoking, the asymptomatic nature of the disease, and the tendency of patients to attribute existing symptoms to smoking appear to contribute to delayed presentation to healthcare facilities, which likely plays a role in the high proportion of advanced-stage diagnoses. Additionally, unlike in other studies, the higher proportion of female patients diagnosed in our cohort was considered to be related to the widespread use of tandoori ovens in our region.
- 25 February 2026
- Published by MediHealth Academy in Journal of Current Hematology & Oncology Research
- Vol. 4 (1) , 12-17
Evaluation of demographic and clinical data of patients diagnosed with lung cancer: a single-center experience
Aims: To retrospectively evaluate the demographic, epidemiological, and clinical characteristics of patients diagnosed with lung cancer. Methods: Patients diagnosed and treated for lung cancer in our medical oncology clinic were included in the study. Patient records were obtained retrospectively from the electronic databases of the hospital. Demographic and clinical characteristics were recorded for each patient. Results: A total of 313 patients diagnosed with lung cancer were included in the study. Mean age was 62.7 ± 10.3 years. Of the patients, 83.4% were male and 16.6% were female. Most common presenting complaints were dyspnea (40.9%) and chest pain (32.2%). Smoking history was present in 66.5% of patients, and 15.3% had a history of tandoori smoke exposure. Radiologically, the most frequent tumor localization was the right upper lobe (38%). Most common histopathological types were squamous cell carcinoma (39.3%), adenocarcinoma (27.2%), and small cell carcinoma (20.1%). Most common disease stage at the time of diagnosis was stage IV (48.9%), followed by stage III (39%), II (10.9%), and I (1.3%). Mean OS was 14 ± 1.4 (range, 11.2–16.8) months. Higher ECOG performance scores and advanced stage were associated with poorer survival. Mean OS was 31 months for females and 13 months for males. Conclusion: The findings obtained in our study were found to be consistent with those of previous research. In Turkey, the high prevalence of smoking, the asymptomatic nature of the disease, and the tendency of patients to attribute existing symptoms to smoking appear to contribute to delayed presentation to healthcare facilities, which likely plays a role in the high proportion of advanced-stage diagnoses. Additionally, unlike in other studies, the higher proportion of female patients diagnosed in our cohort was considered to be related to the widespread use of tandoori ovens in our region.
- Open Access
Serum Kynurenine Pathway Metabolites as Candidate Diagnostic Biomarkers for Pituitary Adenoma: A Case–Control Study
Background and Objectives: Pituitary adenomas are common intracranial tumors lacking specific non-invasive biomarkers. This study aimed to determine whether key metabolites and enzymes of the kynurenine pathway—including indoleamine 2,3-dioxygenase (IDO), kynurenine (KYN), kynurenic acid (KYNA), kynurenine aminotransferase (KAT), quinolinic acid, and picolinic acid—can serve as diagnostic biomarkers distinguishing patients with pituitary adenomas from healthy controls. Materials and Methods: We conducted a single-center, cross-sectional, case–control study with 50 patients with pituitary adenomas and 35 healthy controls. Serum levels of IDO, KYN, KYNA, KAT, quinolinic acid, and picolinic acid were measured via enzyme-linked immunosorbent assay (ELISA). Statistical analyses included group comparisons (t-test/Mann–Whitney U), multivariate logistic regression to identify independent predictors, receiver operating characteristic (ROC) curve analysis to evaluate diagnostic performance (area under the curve, AUC), and partial least squares discriminant analysis (PLS-DA) for multivariate metabolic profiling. Results: Serum kynurenine, kynurenic acid, 3-hydroxykynurenine, picolinic acid, IDO and kynureninase were significantly higher in the pituitary adenoma group than in healthy controls (p < 0.001), while tryptophan, kynurenine aminotransferase, anthranilic acid and quinolinic acid showed no significant differences. ROC analysis demonstrated excellent diagnostic accuracy, with KAT (AUC = 0.923) and KYNA (AUC = 0.901) showing the highest discrimination. Multivariate logistic regression identified IDO, KYN, and KYNA as independent predictors of pituitary adenoma (p < 0.05). PLS-DA of the combined metabolite data also demonstrated clear separation between patients and controls, confirming distinct metabolic profiles between the groups. Conclusions: Kynurenine pathway metabolites and enzymes show strong potential as non-invasive biomarkers for pituitary adenomas. In particular, elevated KAT and KYNA levels demonstrated high diagnostic performance. These findings suggest that a panel of kynurenine pathway metabolites could aid in the early, non-invasive detection of pituitary adenomas.
Open AccessSerum Kynurenine Pathway Metabolites as Candidate Diagnostic Biomarkers for Pituitary Adenoma: A Case–Control Study
Background and Objectives: Pituitary adenomas are common intracranial tumors lacking specific non-invasive biomarkers. This study aimed to determine whether key metabolites and enzymes of the kynurenine pathway—including indoleamine 2,3-dioxygenase (IDO), kynurenine (KYN), kynurenic acid (KYNA), kynurenine aminotransferase (KAT), quinolinic acid, and picolinic acid—can serve as diagnostic biomarkers distinguishing patients with pituitary adenomas from healthy controls. Materials and Methods: We conducted a single-center, cross-sectional, case–control study with 50 patients with pituitary adenomas and 35 healthy controls. Serum levels of IDO, KYN, KYNA, KAT, quinolinic acid, and picolinic acid were measured via enzyme-linked immunosorbent assay (ELISA). Statistical analyses included group comparisons (t-test/Mann–Whitney U), multivariate logistic regression to identify independent predictors, receiver operating characteristic (ROC) curve analysis to evaluate diagnostic performance (area under the curve, AUC), and partial least squares discriminant analysis (PLS-DA) for multivariate metabolic profiling. Results: Serum kynurenine, kynurenic acid, 3-hydroxykynurenine, picolinic acid, IDO and kynureninase were significantly higher in the pituitary adenoma group than in healthy controls (p < 0.001), while tryptophan, kynurenine aminotransferase, anthranilic acid and quinolinic acid showed no significant differences. ROC analysis demonstrated excellent diagnostic accuracy, with KAT (AUC = 0.923) and KYNA (AUC = 0.901) showing the highest discrimination. Multivariate logistic regression identified IDO, KYN, and KYNA as independent predictors of pituitary adenoma (p < 0.05). PLS-DA of the combined metabolite data also demonstrated clear separation between patients and controls, confirming distinct metabolic profiles between the groups. Conclusions: Kynurenine pathway metabolites and enzymes show strong potential as non-invasive biomarkers for pituitary adenomas. In particular, elevated KAT and KYNA levels demonstrated high diagnostic performance. These findings suggest that a panel of kynurenine pathway metabolites could aid in the early, non-invasive detection of pituitary adenomas.
- Open Access
- 26 October 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (4) , 77-81
Evaluation of cardiovascular, bone mineral, and hematological disorders in chronic hemodialysis patients
Aims: The prevalence of cardiovascular diseases, bone mineral disorders, and anemia in patients undergoing continuous hemodialysis is higher than in the normal population. In addition, due to the ongoing renal parenchymal loss in these patients, there is continuous deterioration in bone mineral metabolism. Anemia, a leading hematological disorder, is considered to be one of the most important and frequent complications leading to compromised quality of life. In this study, we aimed to investigate cardiovascular, bone mineral, and hematological disorders in patients undergoing continuous hemodialysis. Methods: Clinical data of 56 patients receiving continuous hemodialysis at Yüzüncü Yıl University Faculty of Medicine Hospital Nephrology Clinic Dialysis Unit between 01.07.2021 and 01.07.2022 were evaluated retrospectively. Echocardiography), dual-energy X-Ray absorptiometry and laboratory parameters were evaluated for each patient. Demographic characteristics and medications were recorded. Due to the retrospective nature of the study, the sample size was not calculated. Results: The study included 56 patients undergoing hemodialysis, comprising 26 (46.4%) men and 30 (53.6%) women. Mean duration of hemodialysis was 5.55±5.09 years. Moreover, 92.9% of the patients were receiving medications, with the most common medications including erythropoiesis-stimulating agents (69.6%), phosphorus binders (48.2%), iron supplements (28.6%), active vitamin D supplements (37.5%), and cinacalcet (12.5%). Cardiovascular diseases were detected in 60.7% of the patients, osteoporosis in 41.1%, and anemia in 78.6%. Conclusion: Cardiovascular disease, bone mineral disorders, and hematological disorders are commonly seen in hemodialysis patients. Hemodialysis patients should be regularly evaluated for complications.
- 26 October 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (4) , 77-81
Open AccessEvaluation of cardiovascular, bone mineral, and hematological disorders in chronic hemodialysis patients
Aims: The prevalence of cardiovascular diseases, bone mineral disorders, and anemia in patients undergoing continuous hemodialysis is higher than in the normal population. In addition, due to the ongoing renal parenchymal loss in these patients, there is continuous deterioration in bone mineral metabolism. Anemia, a leading hematological disorder, is considered to be one of the most important and frequent complications leading to compromised quality of life. In this study, we aimed to investigate cardiovascular, bone mineral, and hematological disorders in patients undergoing continuous hemodialysis. Methods: Clinical data of 56 patients receiving continuous hemodialysis at Yüzüncü Yıl University Faculty of Medicine Hospital Nephrology Clinic Dialysis Unit between 01.07.2021 and 01.07.2022 were evaluated retrospectively. Echocardiography), dual-energy X-Ray absorptiometry and laboratory parameters were evaluated for each patient. Demographic characteristics and medications were recorded. Due to the retrospective nature of the study, the sample size was not calculated. Results: The study included 56 patients undergoing hemodialysis, comprising 26 (46.4%) men and 30 (53.6%) women. Mean duration of hemodialysis was 5.55±5.09 years. Moreover, 92.9% of the patients were receiving medications, with the most common medications including erythropoiesis-stimulating agents (69.6%), phosphorus binders (48.2%), iron supplements (28.6%), active vitamin D supplements (37.5%), and cinacalcet (12.5%). Cardiovascular diseases were detected in 60.7% of the patients, osteoporosis in 41.1%, and anemia in 78.6%. Conclusion: Cardiovascular disease, bone mineral disorders, and hematological disorders are commonly seen in hemodialysis patients. Hemodialysis patients should be regularly evaluated for complications.
- Open Access
- 29 August 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (3) , 58-63
The analysis of patients with diagnose of acute pancreatitis: a retrospective sıngle center study
Aims: Acute pancreatitis is an inflammatory disease of the pancreas and may be limited to the pancreas or may affect many organs and result in death. Different theories have been proposed in its pathogenesis. The aim of this study was to discuss the demographic characteristics, etiological causes and clinical features of patients with acute pancreatitis, whose frequency is not known in our country but which we see frequently in our daily practice. Methods: The files of patients admitted to the gastroenterology clinic between May 2005 and May 2014 and diagnosed with acute pancreatitis were retrospectively reviewed. Age, gender, mode of presentation, cause of acute pancreatitis, clinical features and prognosis were analysed. Results: A total of 630 patients were retrospectively analysed. Of the 630 patients diagnosed with acute pancreatitis, 289 (45.9%) were male and 341 (54.1%) were female. The mean age was 55.58±17.4 years. The most common etiological cause was biliary causes in 420 (66.7%) patients. The most common reason for presentation was abdominal pain and nausea and vomiting in 415 (65.9%) patients. The most common presentation (28%) was in the spring season. 614 (97.4%) patients were discharged with recovery and 16 (2.6%) patients died. It was found that 3 methods (Ranson, APACHE, Atlanta) used in prognosis determination gave similar results. Conclusion: Acute pancreatitis, which can be a mortal disease, has different etiological factors and the most common etiological factor is biliary origin. Abdominal ultrasonography is a valuable method in the detection of biliary pathologies. The most common presentation is abdominal pain accompanied by nausea and vomiting. It was observed that different scoring systems did not differ from each other.
- 29 August 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (3) , 58-63
Open AccessThe analysis of patients with diagnose of acute pancreatitis: a retrospective sıngle center study
Aims: Acute pancreatitis is an inflammatory disease of the pancreas and may be limited to the pancreas or may affect many organs and result in death. Different theories have been proposed in its pathogenesis. The aim of this study was to discuss the demographic characteristics, etiological causes and clinical features of patients with acute pancreatitis, whose frequency is not known in our country but which we see frequently in our daily practice. Methods: The files of patients admitted to the gastroenterology clinic between May 2005 and May 2014 and diagnosed with acute pancreatitis were retrospectively reviewed. Age, gender, mode of presentation, cause of acute pancreatitis, clinical features and prognosis were analysed. Results: A total of 630 patients were retrospectively analysed. Of the 630 patients diagnosed with acute pancreatitis, 289 (45.9%) were male and 341 (54.1%) were female. The mean age was 55.58±17.4 years. The most common etiological cause was biliary causes in 420 (66.7%) patients. The most common reason for presentation was abdominal pain and nausea and vomiting in 415 (65.9%) patients. The most common presentation (28%) was in the spring season. 614 (97.4%) patients were discharged with recovery and 16 (2.6%) patients died. It was found that 3 methods (Ranson, APACHE, Atlanta) used in prognosis determination gave similar results. Conclusion: Acute pancreatitis, which can be a mortal disease, has different etiological factors and the most common etiological factor is biliary origin. Abdominal ultrasonography is a valuable method in the detection of biliary pathologies. The most common presentation is abdominal pain accompanied by nausea and vomiting. It was observed that different scoring systems did not differ from each other.
- Open Access
- 7 February 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (1) , 5-9
Magnesium, calcium and vitamin D levels in polycystic ovarian syndrome: a retrospective single center study
Aims: Polycystic ovary syndrome (PCOS); It is an endocrine-gynecological disorder that affects many women of reproductive age, with chronic anovulation and androgen elevation. Although many pathophysiological processes have been discovered in the development of PCOS; The exact etiology and pathophysiology have not been fully elucidated. Vitamin D is synthesized differently from other vitamins and vitamin D has a hormonal function in the body. Vitamin D is known to have a role in many diseases, as well as its effects on bone metabolism in the body. We aimed to examine the relationship between PCOS and serum vitamin D, calcium and magnesium levels. Methods: A total of 80 cases, including 40 patients diagnosed with PCOS according to the Rotterdam criteria and 40 cases in the normal population, were included in the study. The cases were examined retrospectively. Magnesium, calcium and vitamin D levels of all cases were compared. Additionally, the hemogram parameters, insulin, glucose, insulin resistance, HbA1c, high-density lipoprotein, low-density lipoprotein, triglyceride, total cholesterol, parathormone and phosphorus levels of the cases were compared. Results: There was no difference in magnesium, calcium, vitamin D values between cases with and without polycystic ovary syndrome, and no difference in hemogram parameters, HbA1c, glucose, insulin, parathormone and phosphorus levels between the same groups (p>0.05). When lipid levels were compared, total cholesterol and low-density lipoprotein levels were found to be significantly higher in those without PCOS (p = 0.042). The average age was found to be significantly lower in patients with PCOS (p<0.001). Conclusion: In our study, no significant difference was seen between the two groups in terms of magnesium, calcium and vitamin D levels. Prospective observational studies and randomized controlled studies are needed to more clearly explain the relationship between hormonal and metabolic irregularities and magnesium, calcium and vitamin D levels in PCOS.
- 7 February 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (1) , 5-9
Open AccessMagnesium, calcium and vitamin D levels in polycystic ovarian syndrome: a retrospective single center study
Aims: Polycystic ovary syndrome (PCOS); It is an endocrine-gynecological disorder that affects many women of reproductive age, with chronic anovulation and androgen elevation. Although many pathophysiological processes have been discovered in the development of PCOS; The exact etiology and pathophysiology have not been fully elucidated. Vitamin D is synthesized differently from other vitamins and vitamin D has a hormonal function in the body. Vitamin D is known to have a role in many diseases, as well as its effects on bone metabolism in the body. We aimed to examine the relationship between PCOS and serum vitamin D, calcium and magnesium levels. Methods: A total of 80 cases, including 40 patients diagnosed with PCOS according to the Rotterdam criteria and 40 cases in the normal population, were included in the study. The cases were examined retrospectively. Magnesium, calcium and vitamin D levels of all cases were compared. Additionally, the hemogram parameters, insulin, glucose, insulin resistance, HbA1c, high-density lipoprotein, low-density lipoprotein, triglyceride, total cholesterol, parathormone and phosphorus levels of the cases were compared. Results: There was no difference in magnesium, calcium, vitamin D values between cases with and without polycystic ovary syndrome, and no difference in hemogram parameters, HbA1c, glucose, insulin, parathormone and phosphorus levels between the same groups (p>0.05). When lipid levels were compared, total cholesterol and low-density lipoprotein levels were found to be significantly higher in those without PCOS (p = 0.042). The average age was found to be significantly lower in patients with PCOS (p<0.001). Conclusion: In our study, no significant difference was seen between the two groups in terms of magnesium, calcium and vitamin D levels. Prospective observational studies and randomized controlled studies are needed to more clearly explain the relationship between hormonal and metabolic irregularities and magnesium, calcium and vitamin D levels in PCOS.
- Open Access
- 18 October 2024
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 30, e946471
Effects of Nutritional Protocol Changes on Hemodialysis Adequacy and Patient Health During the COVID-19 Pandemic
Effects of Nutritional Protocol Changes on Hemodialysis Adequacy and Patient Health During the COVID-19 Pandemic - Article abstract #946471
- 18 October 2024
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 30, e946471
Open AccessEffects of Nutritional Protocol Changes on Hemodialysis Adequacy and Patient Health During the COVID-19 Pandemic
Effects of Nutritional Protocol Changes on Hemodialysis Adequacy and Patient Health During the COVID-19 Pandemic - Article abstract #946471
- Open Access
- 30 August 2024
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 17 (2) , 69-75
Nephrological Problems in COVID19 Patients: A Retrospective Single Centre Study
Aim: The SARS CoV-2 virus that emerged in 2019 and the emerging pandemic are full of journeys. The nephrological effects of the pandemic have been a matter of curiosity. In this study, nephrological problems were investigated in COVID-19 positive patients hospitalized in clinical and intensive care units. Materials and Methods: The research is an observational cross-sectional retrospective study. Between November 2020 and November 2021, blood and urine analyzes sent from patients aged 18-90 who were followed up in the COVID-19 Intensive Care Unit and COVID-19 clinics were examined. 79 patients were included in the study. The diagnosis of COVID-19 was made by considering RT-PCR, thorax CT and clinical situation. These 79 patients were compared in terms of acute kidney injury (AKI), electrolyte imbalance and complete urinalysis disorders. Results: AKI was detected in 32.9% of patients. 42.3% of patients with AKI were female, 57.7% were male. 73.1% of the patients with AKI were hospitalized in the intensive care unit. Hematuria and proteinuria were detected in 65% and 27%, respectively. In the examinations performed, 65% hematuria, 27% proteinuria, 44% hyponatremia, 4% hypernatremia, 13% hypokalemia, 11% hyperkalemia, 11% hypophosphatemia, 6% hyperphosphatemia, 9% hypomagnesemia, 3% hypermagnesemia, 24% hypocalcemia and 65% hypoalbuminemia were detected. Conclusion: Acute kidney injury, hematuria and proteinuria were statistically significant in patients diagnosed with COVID-19 and hospitalized and followed up. There are also electrolyte imbalances and hypoalbuminemia in patients. Follow-up of patients with COVID-19 should be carefully monitored in terms of nephrolog
- 30 August 2024
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 17 (2) , 69-75
Open AccessNephrological Problems in COVID19 Patients: A Retrospective Single Centre Study
Aim: The SARS CoV-2 virus that emerged in 2019 and the emerging pandemic are full of journeys. The nephrological effects of the pandemic have been a matter of curiosity. In this study, nephrological problems were investigated in COVID-19 positive patients hospitalized in clinical and intensive care units. Materials and Methods: The research is an observational cross-sectional retrospective study. Between November 2020 and November 2021, blood and urine analyzes sent from patients aged 18-90 who were followed up in the COVID-19 Intensive Care Unit and COVID-19 clinics were examined. 79 patients were included in the study. The diagnosis of COVID-19 was made by considering RT-PCR, thorax CT and clinical situation. These 79 patients were compared in terms of acute kidney injury (AKI), electrolyte imbalance and complete urinalysis disorders. Results: AKI was detected in 32.9% of patients. 42.3% of patients with AKI were female, 57.7% were male. 73.1% of the patients with AKI were hospitalized in the intensive care unit. Hematuria and proteinuria were detected in 65% and 27%, respectively. In the examinations performed, 65% hematuria, 27% proteinuria, 44% hyponatremia, 4% hypernatremia, 13% hypokalemia, 11% hyperkalemia, 11% hypophosphatemia, 6% hyperphosphatemia, 9% hypomagnesemia, 3% hypermagnesemia, 24% hypocalcemia and 65% hypoalbuminemia were detected. Conclusion: Acute kidney injury, hematuria and proteinuria were statistically significant in patients diagnosed with COVID-19 and hospitalized and followed up. There are also electrolyte imbalances and hypoalbuminemia in patients. Follow-up of patients with COVID-19 should be carefully monitored in terms of nephrolog
- 25 July 2022
- Published by Academician Publishing
- p. 165-172
Endokrin Sistem Hastalıkları ve Kronobiyoloji
Endokrin sistem ile kronobiyoloji arasındaki ilişkiyi inceleyen bu bilimsel yazı, sirkadiyen ritmi düzenleyen melatonin hormonunun metabolik hastalıklar üzerindeki fonksiyonlarını ele almaktadır. Triptofandan sentezlenen ve geceleri daha fazla salgılanan melatonin; uyku, bağışıklık, antioksidan mekanizmalar ve üreme fonksiyonları üzerinde çok yönlü etkilere sahiptir. En güçlü antioksidan olarak kabul edilen bu hormon, diyabetes mellitusta bozulan antioksidan sistemini regüle ederek glukoz homeostazını desteklerken; vücut yağ oranını ve enerji sirkülasyonunu etkileyerek obezite gelişimini azaltmaktadır. Akromegali, tiroid hastalıkları ve Cushing sendromu gibi endokrin patolojilerde melatonin düzeylerinde ve sirkadiyen ritimde belirgin değişiklikler saptanmış olup; hormonun tiroid tümör büyümesini yavaşlattığı ve kortizol seviyeleriyle ters orantılı çalıştığı gözlenmiştir. Ayrıca üreme sisteminde antigonadal etkinlik gösteren melatonin, testosteron salınımını ve sperm motilitesini azaltabilmekte, foliküler sıvıda yüksek oranda bulunarak progesteron sentezinde rol oynamaktadır. Sonuç olarak, melatoninin endokrin hastalıkların patogenezindeki düzenleyici ve koruyucu rolü, gelecekteki klinik tedaviler için güçlü bir potansiyel sunmaktadır. Investigating the relationship between the endocrine system and chronobiology, this scientific paper discusses the functions of the melatonin hormone, which regulates the circadian rhythm, on metabolic diseases. Melatonin, synthesized from tryptophan and secreted more at night, has multifaceted effects on sleep, immunity, antioxidant mechanisms, and reproductive functions. Considered the most potent antioxidant, this hormone regulates the disrupted antioxidant system in diabetes mellitus to support glucose homeostasis, while decreasing obesity development by affecting body fat ratio and energy circulation. Significant changes in melatonin levels and circadian rhythms have been detected in endocrine pathologies such as acromegaly, thyroid diseases, and Cushing's syndrome; it has been observed that the hormone slows thyroid tumor growth and operates in inverse proportion to cortisol levels. Furthermore, demonstrating antigonadal activity in the reproductive system, melatonin can reduce testosterone secretion and sperm motility, and plays a role in progesterone synthesis by being present in high concentrations within the follicular fluid. Consequently, the regulatory and protective role of melatonin in the pathogenesis of endocrine diseases offers a strong potential for future clinical treatments.
- 25 July 2022
- Published by Academician Publishing
- p. 165-172
Endokrin Sistem Hastalıkları ve Kronobiyoloji
Endokrin sistem ile kronobiyoloji arasındaki ilişkiyi inceleyen bu bilimsel yazı, sirkadiyen ritmi düzenleyen melatonin hormonunun metabolik hastalıklar üzerindeki fonksiyonlarını ele almaktadır. Triptofandan sentezlenen ve geceleri daha fazla salgılanan melatonin; uyku, bağışıklık, antioksidan mekanizmalar ve üreme fonksiyonları üzerinde çok yönlü etkilere sahiptir. En güçlü antioksidan olarak kabul edilen bu hormon, diyabetes mellitusta bozulan antioksidan sistemini regüle ederek glukoz homeostazını desteklerken; vücut yağ oranını ve enerji sirkülasyonunu etkileyerek obezite gelişimini azaltmaktadır. Akromegali, tiroid hastalıkları ve Cushing sendromu gibi endokrin patolojilerde melatonin düzeylerinde ve sirkadiyen ritimde belirgin değişiklikler saptanmış olup; hormonun tiroid tümör büyümesini yavaşlattığı ve kortizol seviyeleriyle ters orantılı çalıştığı gözlenmiştir. Ayrıca üreme sisteminde antigonadal etkinlik gösteren melatonin, testosteron salınımını ve sperm motilitesini azaltabilmekte, foliküler sıvıda yüksek oranda bulunarak progesteron sentezinde rol oynamaktadır. Sonuç olarak, melatoninin endokrin hastalıkların patogenezindeki düzenleyici ve koruyucu rolü, gelecekteki klinik tedaviler için güçlü bir potansiyel sunmaktadır. Investigating the relationship between the endocrine system and chronobiology, this scientific paper discusses the functions of the melatonin hormone, which regulates the circadian rhythm, on metabolic diseases. Melatonin, synthesized from tryptophan and secreted more at night, has multifaceted effects on sleep, immunity, antioxidant mechanisms, and reproductive functions. Considered the most potent antioxidant, this hormone regulates the disrupted antioxidant system in diabetes mellitus to support glucose homeostasis, while decreasing obesity development by affecting body fat ratio and energy circulation. Significant changes in melatonin levels and circadian rhythms have been detected in endocrine pathologies such as acromegaly, thyroid diseases, and Cushing's syndrome; it has been observed that the hormone slows thyroid tumor growth and operates in inverse proportion to cortisol levels. Furthermore, demonstrating antigonadal activity in the reproductive system, melatonin can reduce testosterone secretion and sperm motility, and plays a role in progesterone synthesis by being present in high concentrations within the follicular fluid. Consequently, the regulatory and protective role of melatonin in the pathogenesis of endocrine diseases offers a strong potential for future clinical treatments.